Yayun Xu

Potential value of Interleukin-6 as a diagnostic biomarker in human MDD and the antidepressant effect of its receptor antagonist tocilizumab in lipopolysaccharide-challenged rats.

Qingrong Xia, Jinfang Ge, Xinran Gao, 2023, International immunopharmacology.

Serum cytokines-based biomarkers in the diagnosis and monitoring of therapeutic response in patients with major depressive disorder.

Jun Liang, F. Shan, Q. Xia, 2023, International immunopharmacology.

Peripheral blood cytokines as potential diagnostic biomarkers of suicidal ideation in patients with first-episode drug-naïve major depressive disorder

Yanhong Sun, Jun Liang, F. Shan, 2022, Frontiers in Public Health.

Comparison of serum cytokines levels in normal-weight and overweight patients with first-episode drug-naïve major depressive disorder

Yanhong Sun, Jun Liang, F. Shan, 2022, Frontiers in Endocrinology.

Effects of Modified Electroconvulsive Therapy on Serum Cortisol, Nesfatin-1, and Pro-inflammatory Cytokine Levels in Elderly Patients With Treatment-Resistant Depression

Yang Chen, Xuefeng Xie, Biao Dai, 2022, Frontiers in Endocrinology.

Serum Cortisol, Nesfatin-1, and IL-1β: Potential Diagnostic Biomarkers in Elderly Patients with Treatment-Resistant Depression

Q. Xia, Biao Dai, Xiaoping Wu, 2022, Clinical interventions in aging.

Cytokine profile in first-episode drug-naïve major depressive disorder patients with or without anxiety

Jun Liang, Q. Xia, Yuanyuan Zhang, 2024, BMC psychiatry.

Plasma Nesfatin-1: Potential Predictor and Diagnostic Biomarker for Cognitive Dysfunction in T2DM Patient

J. Ge, Yayun Xu, Yue-sheng Yu, 2021, Diabetes, metabolic syndrome and obesity : targets and therapy.